Viewing Study NCT06353893



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06353893
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-06-13
First Post: 2024-03-13

Brief Title: MRI Evaluation of Integrity Bio-Inductive Implant for Rotator Cuff Tears
Sponsor: Foundation for Orthopaedic Research and Education
Organization: Foundation for Orthopaedic Research and Education

Study Overview

Official Title: Postoperative MRI Evaluation of the Integrity Bio-inductive Implant Augmentation of Rotator Cuff Tears of the Shoulder
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to evaluate the effectiveness and safety of the Integrity bio-inductive implant in treating partial and full thickness rotator cuff tears The main questions it aims to answer are

How does the application of the Integrity implant affect patient-reported outcome measures PROMs such as ASES SANE and PROMIS
What are the imaging characteristics of the rotator cuff tears at 3 and 6 months postoperatively when using the Integrity implant

Postoperative MRIs will be obtained from 10 consecutive patients who have undergone rotator cuff repair using the Integrity implant at 3 and 6 months after surgery Participants include those with partial and full thickness tears treated with different surgical techniques involving the implant They may receive either isolated onlay use of the graft for partial tears or augmentation of a standard single or double row repair with the graft applied to the superior surface of the repair
Detailed Description: The aim of this prospective non-randomized open-label single-arm study is to evaluate the safety and effectiveness of the newly FDA-cleared Integrity graft for various types of rotator cuff repairs This study incorporates preoperative assessments as well as follow-up assessments at 3 months and 6 months postoperatively The primary objective is to document the safety profile of the Integrity graft by monitoring device-related adverse events throughout the study duration Additionally the study aims to assess the post-market effectiveness of the Integrity implant using patient-reported outcome measures and establish normal or standard findings on MRI to aid surgeons in clinical decision-making

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None